Search

Your search keyword '"Horike-Pyne, Martha"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Horike-Pyne, Martha" Remove constraint Author: "Horike-Pyne, Martha"
122 results on '"Horike-Pyne, Martha"'

Search Results

1. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

2. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

3. The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones

4. Considerations for reporting variants in novel candidate genes identified during clinical genomic testing

5. Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities

6. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

7. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

8. De novo variants in DENND5B cause a neurodevelopmental disorder

9. Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections

10. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

11. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

12. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

13. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

14. Beyond the exome: What’s next in diagnostic testing for Mendelian conditions

15. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

16. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

17. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

18. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

19. Precision medicine for developmental and epileptic encephalopathies in Africa—strategies for a resource-limited setting

20. Returning integrated genomic risk and clinical recommendations: The eMERGE study

21. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

22. Rare loss of function variants in candidate genes and risk of colorectal cancer

23. De novo variants in DENND5B cause a neurodevelopmental disorder

24. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

25. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

26. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

27. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

28. Synchronized long-read genome, methylome, epigenome, and transcriptome for resolving a Mendelian condition

29. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

30. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

31. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

33. Dominant-negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome

34. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

35. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

36. Returning integrated genomic risk and clinical recommendations: The eMERGE study

37. Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital

38. Full-length Isoform Sequencing for Resolving the Molecular Basis of Charcot-Marie-Tooth 2A.

39. Full-length isoform sequencing for resolving the molecular basis of Charcot-Marie-Tooth 2A

40. Precision medicine for developmental and epileptic encephalopathies in Africa—strategies for a resource-limited setting

41. P099: Mosaic variant in RHOA in an adolescent with a multisystem disorder composed of congenital and progressive anomalies

43. Dominant‐negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome.

44. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy

45. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

46. Centers for Mendelian Genomics: A decade of facilitating gene discovery

47. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

48. Dual diagnosis of UQCRFS1-related mitochondrial complex III deficiency and recessive GJA8-related cataracts

49. Patients' choices for return of exome sequencing results to relatives in the event of their death.

50. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

Catalog

Books, media, physical & digital resources